Evidence map›Paper›PMID 40635309›Full record

ArticleEncephalitis (Seoul, Korea)2025

Anti-N-methyl-ᴅ-aspartate receptor encephalitis preceding stroke: report of an unusual case with literature review.

Arpan Mitra, Niraj Kumar Srivastava, Ankur Vivek, Vijaya Nath Mishra, Abhishek Pathak

Abstract readCase Reports
In one paragraph

Article in Encephalitis (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arpan MitraDepartment of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Niraj Kumar SrivastavaDepartment of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Ankur VivekDepartment of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Vijaya Nath MishraDepartment of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Abhishek PathakDepartment of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-N-methyl-ᴅ-aspartate (anti-NMDA) receptor encephalitis is a well-known autoimmune encephalitis caused by antibodies against the GluN1 subunit of the anti-NMDA receptor (anti-NMDAR). Stroke, characterized by abrupt focal neurological deficits due to ischemic or hemorrhagic vascular insults, is rarely preceded by anti-NMDAR encephalitis. Here, we described a case of a 69-year-old female without any prior comorbidities who presented with acute stroke and left hemiparesis with a history of recent onset of neuropsychiatric symptoms. Her cerebrospinal fluid was positive for anti-NMDAR antibody, and significant improvement was noticed after the initiation of immunotherapy. In this patient, stroke occurred following anti-NMDAR encephalitis; however, the pathophysiological link between the two remains unclear. This case presents an interesting and rare clinical intersection between stroke and anti-NMDAR encephalitis, highlighting the difficulty of neurological diagnosis. Due to the unusual association of such pathological conditions, this case contributes to the broader understanding of potential connections between stroke and autoimmune encephalitis, emphasizing the need for a multidisciplinary approach to diagnosis and management.

Indexed as

Anti-N-methyl-ᴅ-aspartate receptor encephalitisAutoimmune encephalitisCentral nervous systemStroke

Identifiers

PMID40635309
PMCPMC12268045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.